<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by Nick Ortego on Medium]]></title>
        <description><![CDATA[Stories by Nick Ortego on Medium]]></description>
        <link>https://medium.com/@nickortego?source=rss-15455b1c83d5------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/1*JAtsJ7NpkuEK_q99AdfZ5g.jpeg</url>
            <title>Stories by Nick Ortego on Medium</title>
            <link>https://medium.com/@nickortego?source=rss-15455b1c83d5------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Tue, 17 Nov 2026 09:44:36 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@nickortego/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[GLP-1s Don’t Kill Muscle — They Might Actually Save It]]></title>
            <link>https://medium.com/@nickortego/glp-1s-dont-kill-muscle-they-might-actually-save-it-9f2d1264f3c8?source=rss-15455b1c83d5------2</link>
            <guid isPermaLink="false">https://medium.com/p/9f2d1264f3c8</guid>
            <category><![CDATA[glp1-weight-loss-meds]]></category>
            <category><![CDATA[fitness]]></category>
            <category><![CDATA[resistance-training]]></category>
            <category><![CDATA[glp1-weight-loss]]></category>
            <category><![CDATA[glp-1]]></category>
            <dc:creator><![CDATA[Nick Ortego]]></dc:creator>
            <pubDate>Tue, 15 Apr 2025 17:49:15 GMT</pubDate>
            <atom:updated>2025-04-23T11:03:28.327Z</atom:updated>
            <content:encoded><![CDATA[<h3>GLP-1s Don’t Kill Muscle — They Might Actually Save It</h3><p><em>Rethinking the real effects of Ozempic, Mounjaro, and other GLP-1s on muscle mass.</em></p><p>Not long ago, a client walked into my studio with a blend of curiosity and caution in her voice.</p><blockquote><strong><em>Client:</em></strong><em> My doctor wants me to try this shot to help me lose weight. It’s actually a diabetes medication.<br> </em><strong><em>Me:</em></strong><em> Interesting… Do you know how it works?<br> </em><strong><em>Client:</em></strong><em> Something about slowing digestion?<br> </em><strong><em>Me:</em></strong><em> Sounds like Byetta. What’s it called?<br> </em><strong><em>Client:</em></strong><em> Ozempic.</em></blockquote><p>One quick search later, and I realized she was talking about a <strong>GLP-1 receptor agonist</strong>, a class of medications I hadn’t thought much about since the buzz around Byetta (aka exenatide) fizzled out years ago.</p><p>But this wasn’t 2010. This was the rise of <strong>Ozempic, Mounjaro, and Zepbound</strong> — a new wave of <strong>GLP-1 mimicking drugs</strong> designed for blood sugar regulation, but now at the forefront of treating obesity.</p><h3>Everyone Knows Someone on “The Shot”</h3><p>At first, I was skeptical. As a fitness professional with more than 25 years in the industry, I’ve seen hype come and go. Back in the day, Byetta promised big things for weight loss, too — but it never delivered.</p><p>This time feels different.</p><p>Not only are these new GLP-1s helping people shed weight, but many are keeping it off. Long-term success stories are emerging and this caught my attention. As a trainer, I wanted to dig deeper into the science.</p><h3>The Side Effect That Caught My Eye: Muscle Loss</h3><p>Yes, like any drug, GLP-1s come with side effects. Some are mild and expected (hello, nausea), and a few are more serious, though rare.</p><p>But the one that really raised my eyebrow?</p><p><strong>Muscle loss.</strong></p><p>An article published in <em>The Lancet Diabetes &amp; Endocrinology</em> (Prado et al., 2024) reported that GLP-1 drugs may cause significant muscle loss — with estimates ranging from <strong>25% to 39%</strong> of the total weight lost.</p><p>That number sounded alarming. But was it the whole story?</p><h3>Let’s Get This Straight: GLP-1s Don’t Cause Muscle Loss</h3><p>I’ve said it to clients for years:</p><blockquote>“If you lose weight without resistance training, you’re going to lose muscle.”</blockquote><p>This isn’t new. It’s <strong>basic physiology</strong>.</p><p>When you create a calorie deficit — whether through diet, illness, or medication — the body loses both fat and lean tissue. The proportions vary, but the trend is consistent: <strong>without strength training, you’re not just shrinking fat cells; you’re shrinking muscle too</strong>.</p><p>That’s not a GLP-1 problem. That’s a <strong>calorie deficit problem</strong>.</p><p>In fact, a study by Wu et al. (2024) found that <strong>45% of the weight lost</strong> in women who followed a low-calorie diet without exercise came from <strong>muscle mass</strong>. That’s more than the 25–39% reported with GLP-1s.</p><p>So are GLP-1s causing muscle loss?</p><p>Or are they just producing the same effects we’ve seen for decades with diet-only weight loss?</p><h3>Could GLP-1s Actually Protect Muscle?</h3><p>Now here’s where it gets interesting.</p><p>After questioning the narrative that GLP-1s destroy muscle, I wanted to know: <strong>Is there any evidence they could actually help preserve or support it?</strong></p><p>Insulin, which is also used to control blood glucose, is also anabolic (growth-promoting) to muscle cells. Could GLP-1 and the drugs that mimic it have a similar effect on muscle cells?</p><p>While I couldn’t find the “perfect” study — a double-blind trial with equal diets, no exercise, and careful muscle mass tracking — I <em>did</em> find some fascinating research.</p><p>Here’s what I found:</p><h3>🔬 GLP-1 Prevent Muscle Atrophy (Rodent Study)</h3><p>A 2020 study found that a <strong>GLP-1 analog reduced muscle atrophy</strong> in rodents exposed to stressors. It even promoted new muscle cell formation in lab conditions.<br> <strong>(Gurjar et al., 2020)</strong></p><h3>🧬 GLP-1 Increases Endurance &amp; Mitochondria (Rodent Study)</h3><p>GLP-1 activity in muscle cells <strong>boosted endurance and mitochondrial biogenesis</strong> — a marker of healthier, more efficient muscle.<br> <strong>(Wu et al., 2022)</strong></p><h3>💪 GLP-1 Ameliorates Muscle Wasting (Rodent Study)</h3><p>GLP-1 drugs <strong>reduced muscle wasting</strong> by suppressing <strong>myostatin</strong>, a hormone known to inhibit muscle growth.<br> <strong>(Hong et al., 2019)</strong></p><h3>🧓 GLP-1 Enhances Protein Synthesis in Older Men (Human Study!)</h3><p>GLP-1 infusions <strong>improved post-meal muscle protein synthesis</strong> in men in their 70s — a population known for “anabolic resistance.”<br> <strong>(Abdulla et al., 2020)</strong></p><h3>What This Means for You (and Your Muscles)</h3><p>Here’s the takeaway:</p><p>📉 GLP-1 drugs <strong>don’t inherently cause muscle loss</strong>.<br> 📈 They may, under certain conditions, <strong>help protect muscle</strong> — or even improve its quality and function.</p><p>The real key to muscle preservation (or growth) during weight loss remains what it’s always been:<br> ✅ <strong>Adequate protein</strong><br> ✅ <strong>Strength training</strong><br> ✅ <strong>Smart coaching</strong></p><p>And now? Possibly <strong>GLP-1s</strong> — when used wisely.</p><h3>Want to Lose Weight Without Sacrificing Muscle?</h3><p>Whether you’re using GLP-1s or taking a drug-free approach, <strong>preserving muscle mass is non-negotiable</strong> — and I can help you do it right.</p><p>I combine science-backed strategies, custom training plans, and real-world coaching to help you get lean <strong>without getting weak</strong>.</p><p><a href="https://n2action.wordpress.com/online-fitness-coaching/">👉 <strong>Click here to learn how we can build a fat-loss strategy that protects your muscle and accelerates your results.</strong></a></p><h3>References</h3><p>Abdulla, H., et al. (2020). <em>Glucagon-like peptide 1 infusions overcome anabolic resistance to feeding in older human muscle</em>. <em>Aging Cell, 19</em>(5), e13202. <a href="https://doi.org/10.1111/acel.13202">https://doi.org/10.1111/acel.13202</a><br> Gurjar, A. A., et al. (2020). <em>Long-acting GLP-1 analog liraglutide ameliorates skeletal muscle atrophy in rodents</em>. <em>Metabolism, 103</em>, 154044. <a href="https://doi.org/10.1016/j.metabol.2019.154044">https://doi.org/10.1016/j.metabol.2019.154044</a><br> Hong, Y., et al. (2019). <em>Amelioration of muscle wasting by glucagon-like peptide-1 receptor agonist in muscle atrophy</em>. <em>Journal of Cachexia, Sarcopenia and Muscle, 10</em>(4), 903–918. <a href="https://doi.org/10.1002/jcsm.12434">https://doi.org/10.1002/jcsm.12434</a><br> Prado, C. M., et al. (2024). <em>Muscle matters: The effects of medically induced weight loss on skeletal muscle</em>. <em>The Lancet Diabetes &amp; Endocrinology, 12</em>(11), 785–787. <a href="https://doi.org/10.1016/S2213-8587(24)00272-9">https://doi.org/10.1016/S2213-8587(24)00272-9</a><br> Wu, L., et al. (2022). <em>GLP-1 regulates exercise endurance and skeletal muscle remodeling via GLP-1R/AMPK pathway</em>. <em>Biochimica et Biophysica Acta — Molecular Cell Research, 1869</em>(9), 119300. <a href="https://doi.org/10.1016/j.bbamcr.2022.119300">https://doi.org/10.1016/j.bbamcr.2022.119300</a><br> Wu, X., et al. (2024). <em>Exercise combined with a low-calorie diet improves body composition, attenuates muscle mass loss, and regulates appetite in adult women with high body fat percentage but normal BMI</em>. <em>Sports, 12</em>(4), 91. <a href="https://doi.org/10.3390/sports12040091">https://doi.org/10.3390/sports12040091</a></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=9f2d1264f3c8" width="1" height="1" alt="">]]></content:encoded>
        </item>
    </channel>
</rss>